CDC42EP3 and cytomegalovirus infection: The results indicated that the developed mosaic symptoms emerged following CMV infection at 16 dpi; however, the administration of 33504-Borg2 postponed symptom onset by five days, with mild symptoms manifesting at 23 dpi (Figure 4).